Data as of Oct 24
| +0.42 / +1.56%|
The 5 analysts offering 12-month price forecasts for Auspex Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 42.00 and a low estimate of 37.00. The median estimate represents a +46.04% increase from the last price of 27.39.
The current consensus among 5 polled investment analysts is to Buy stock in Auspex Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.